Arrow
Arrow
Liv Hekimleri
Arrow
Prof. Dr. Meral Günaldı
Prof. Dr. Meral Günaldı
Prof. Dr.

Meral Günaldı

Liv Hospital Ulus
Tıbbi Onkoloji
İlgi Alanları
    • Meme kanseri
    • Yumurtalık Kanseri
    • Rahim Kanseri
    • Serviks Tümörü
    • Akciğer kanseri
    • Kolorektal kanser
    • Pankreas kanseri
    • Glioblastoma multiforme
    • Beyin Tümörleri
Özgeçmişim
Yayınlarım
Üyeliklerim
Ödüllerim
Katıldığım Kurslar
21
h-index
Eğitim:
  • Lisans: Tıp Fakültesi, Karadeniz Teknik Üniversitesi (1994–2001)
  • Tıpta Uzmanlık: İç Hastalıkları, Okmeydanı Eğitim Araştırma Hastanesi (2004–2009)
  • Yan Dal Uzmanlık: Tıbbi Onkoloji, Çukurova Üniversitesi Tıp Fakültesi (2009–2013)
  • Doçentlik: İç Hastalıkları, Acıbadem Üniversitesi (2016)
  • Profesörlük: İstanbul Aydın Üniversitesi (2022)
Deneyim:
  • 2001–2002 : Bartın Göçgün Demirci Köyü, Kozcağız Merkez Sağlık Ocağı (Pratisyen Hekim)
  • 2002–2003 : İÜ İstanbul Tıp Fakültesi Nöroloji ABD (Asistan)
  • 2004–2009 : Okmeydanı Eğitim Araştırma Hastanesi, İç Hastalıkları (Asistan)
  • 2009–2013 : Çukurova Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji (Asistan)
  • 2013–2016 : İstanbul Bakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi (Tıbbi Onkoloji Uzmanı)
  • 2016–2018 : Özel Neolife Tıp Merkezi (Doçent)
  • 2017–2023 : İstanbul Aydın Üniversitesi Tıp Fakültesi, Florya Medical Park Hastanesi (Doçent/Profesör)
  • 2023–2025 : Medicana Ataköy Hastanesi (Profesör, Tıbbi Onkoloji Uzmanı)
  • 2025–... : Liv Hospital Ulus
Uluslararası Hakemli Dergilerde Yayımlanan Makaleler:
  • Günaldi, M., Helvaci, A., Yildirim, N. D., Kiskaç, M., & Küçükkaya, R. D. (2009). Acute myocardial infarction in a patient with hemophilia A and factor V Leiden mutation. *Cardiology Journal, 16*(5), 458–461.
  • Duman, B. B., Kara, I. O., Günaldi, M., & Erçolak, V. (2011). Primary cutaneous small-cell carcinoma: A case report. *Medical Oncology, 28*(Suppl 1), S634–S635. https://doi.org/10.1007/s12032-010-9672-3
  • Duman, B. B., Kara, I. O., Günaldi, M., & Ercolak, V. (2011). Malignant mixed Mullerian tumor of the ovary with two cases and review of the literature. *Archives of Gynecology and Obstetrics, 283*(6), 1363–1368. https://doi.org/10.1007/s00404-011-1845-6
  • Gunaldi, M., Helvaci, A., Demirel Yildirim, N., Aydin, D., & Kara, N. (2011). Multiple myeloma with serous membrane involvement and increased CA-125 and CA 15-3. *Journal of BUON, 16*(4), 778.
  • Günaldi, M., Oguz Kara, I., Duman, B. B., & Gumurdulu, D. (2012). Primary intrapulmonary thymoma associated with myasthenia gravis. *General Thoracic and Cardiovascular Surgery, 60*(9), 610–613. https://doi.org/10.1007/s11748-012-0064-9
  • Duman, B. B., Paydas, S., Tetiker, T., Gunaldı, M., Afsar, C. U., Erçolak, V., Haksöyler, V., & Dilli, M. Ş. (2012). Capecitabine-induced hypertriglyceridemia and hyperglycemia: Two cases. *Pharmacology, 90*(3–4), 212–215. https://doi.org/10.1159/000342382
  • Duman, B. B., Afşar, Ç. U., Günaldi, M., Sahin, B., Kara, I. O., Erkisi, M., & Erçolak, V. (2012). Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients. *Asian Pacific Journal of Cancer Prevention, 13*(8), 4119–4123.
  • Duman, B. B., Gunaldi, M., Ercolak, V., Afsar, C. U., Sahin, B., Erkisi, I. M., Kara, O., Paydas, S., Gönlüsen, G., & Sertdemir, Y. (2012). Retrospective analysis of 498 primary soft tissue sarcomas in a single Turkish centre. *Asian Pacific Journal of Cancer Prevention, 13*(8), 4125–4128.
  • Gunaldi, M., Kara, I. O., Duman, B. B., & Ercolak, V. (2012). Primary intracerebral myeloid sarcoma. *Onkologie, 35*(11), 694–697. https://doi.org/10.1159/000343953
  • Günaldi, M., Paydas, S., & Afsar, C. U., & Doran, F. (2013). Coexistence of tuberous sclerosis complex and malignant melanoma. *Singapore Medical Journal, 54*(11), e233–e235.
  • Günaldı, M., Paydaş, S., Usul Afşar, C., Bozkurt Duman, B., & Erçolak, V., Haksöyler, V. (2013). Carbamazepine and multiple myeloma: Possible interaction. *Turkish Journal of Haematology, 30*(1), 83–84. https://doi.org/10.4274/tjh.2012.0153
  • Usul Afşar, C., Paydaş, S., Günaldı, M., Bozkurt Duman, B., Erçolak, V., Zorludemir, S., & Açıkalın, A. (2013). Sweet syndrome in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma: Curious lymphocyte/neutrophil fluctuations. *Turkish Journal of Haematology, 30*(4), 413–415. https://doi.org/10.4274/Tjh.2012.0055
  • Erçolak, V., Kara, O., Günaldı, M., Usul Afşar, C., Bozkurt Duman, B., Açıkalın, A., Ergin, M., & Erdoğan, S. (2014). Bilateral primary adrenal non-Hodgkin lymphoma. *Turkish Journal of Haematology, 31*(2), 205–206. https://doi.org/10.4274/tjh.2013.0195
  • Gunaldi, M., Kara, I. O., Duman, B. B., Afsar, C. U., Ergin, M., & Avci, A. (2014). A new approach to the treatment of metastatic paraganglioma: Sorafenib. *Cancer Research and Treatment, 46*(4), 411–414.
  • Sözütek, D., Yanık, S., Akkoca, A. N., Sözütek, A., Ozdemir, Z. T., Avşar, C. U., Günaldı, M., Sahin, B., & Doron, F. (2014). Diagnostic and prognostic roles of DOG1 and Ki-67, in GIST patients with localized or advanced/metastatic disease. *International Journal of Clinical and Experimental Medicine, 7*(7), 1914–1922.
  • Ercolak, V., Paydas, S., Ergin, M., Ates, B. T., Duman, B. B., Gunaldi, M., & Afsar, C. U. (2014). Abdominal actinomycosis with multiple myeloma: A case report. *Oncology Letters, 8*(4), 1876–1878.
  • Paydaş, S., Ozdoğu, H., Günaldı, M., Haksöyler, V., Açıkalın, A., & Ergin, M. (2014). Extramedullary myeloid tumor involving the pancreas: A case report and review of the literature. *Turkish Journal of Haematology, 31*(3), 295–300. https://doi.org/10.4274/tjh.2013.0195
  • Günaldı, M., Erkisi, M., Afşar, C. U., Erçolak, V., Paydas, S., Kara, I. O., Sahin, B., Gulec, U. K., & Secilmis, A. (2014). Evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisms in Turkish breast cancer patients receiving tamoxifen treatment. *Pharmacology, 94*(3–4), 183–189.
  • Afsar, C. U., Gunaldi, M., Kum, P., Sahin, B., Erkisi, M., Kara, I. O., Paydas, S., Duman, B. B., Ercolak, V., Karaca, F., Uyeturk, U., & Guner, S. I. (2014). Pancreatic carcinoma, thrombosis and mean platelet volume: Single center experience from the southeast region of Turkey. *Asian Pacific Journal of Cancer Prevention, 15*(21), 9143–9146.
  • Gunaldi, M., Duman, B. B., Afsar, C. U., Paydas, S., Erkisi, M., Kara, I. O., & Sahin, B. (2016). Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study. *Journal of Oncology Pharmacy Practice, 22*(2), 242–247.
  • Karaca, F., Afsar, C. U., Gunaldi, M., Erkurt, E., Ercolak, V., Sertdemir, Y., & Paydas, S. (2015). Alterations of ghrelin with weights and correlation among ghrelin, cytokine and survival in patients receiving chemoradiotherapy for gastrointestinal cancers. *International Journal of Clinical and Experimental Medicine, 8*(1), 876–882.
  • Okuturlar, Y., Gunaldi, M., Tiken, E. E., Oztosun, B., Inan, Y. O., Ercan, T., Tuna, S., Kaya, A. O., Harmankaya, O., & Kumbasar, A. (2015). Utility of peripheral blood parameters in predicting breast cancer risk. *Asian Pacific Journal of Cancer Prevention, 16*(6), 2409–2412.
  • Gunaldi, M., Afsar, C. U., Okuturlar, Y., Gedikbasi, A., Kocoglu, H., Kural, A., Akarsu, C., Gunduz, U., & Tiken, E. E. (2015). Elevated serum levels of heat shock protein 70 are associated with breast cancer. *Tohoku Journal of Experimental Medicine, 236*(2), 97–102. https://doi.org/10.1620/tjem.236.97
  • Ercolak, V., Paydas, S., Bagir, E., Ergin, M., Seydaoglu, G., Celik, H., Yavu, B., Tanriverdi, K., Gunaldi, M., Afsar, C. U., & Duman, B. B. (2015). PRAME expression and its clinical relevance in Hodgkin's lymphoma. *Acta Haematologica, 134*(4), 199–207.
  • Gunaldi, M., Goksu, S., Erdem, D., Gunduz, S., Okuturlar, Y., Tiken, E., Kahraman, S., Inan, Y. O., Genc, T. B., & Yildirim, M. (2015). Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: A multicenter study. *International Journal of Clinical and Experimental Medicine, 8*(4), 5937–5942.
  • Günaldi, M., Afsar, C. U., Duman, B. B., Kara, I. O., Tatli, U., & Sahin, B. (2015). Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws. *Oncology Letters, 10*(1), 439–442.
  • Karabulut, M., Gunaldi, M., Alis, H., Afsar, C. U., Karabulut, S., Serilmez, M., Akarsu, C., Seyit, H., & Aykan, N. F. (2016). Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma. *Clinical and Translational Oncology, 18*(2), 160–171.
  • Okuturlar, Y., Gedikbasi, A., Akalin, N., Gunaldi, M., Yilmaz, D., Mert, M., Harmankaya, O., Soylu, A., Karakaya, P., & Kumbasar, A. (2016). Serum paraoxonase 1 activity in patients with iron deficiency anemia. *Archives of Medical Science, 12*(4), 697–703. https://doi.org/10.5114/aoms.2015.48730
  • Okuturlar, Y., Ozkalemkas, F., Ener, B., Serin, S. O., Kazak, E., Ozcelik, T., Ozkocaman, V., Ozkan, H. A., Akalin, H., Gunaldi, M., & Ali, R. (2015). Serum galactomannan levels in the diagnosis of invasive aspergillosis. *Korean Journal of Internal Medicine, 30*(6), 899–905.
  • Ercolak, V., Sahin, B., Gunaldi, M., Duman, B. B., & Afsar, C. U. (2015). Efficacy of paclitaxel in the treatment of Kaposi sarcoma. *European Review for Medical and Pharmacological Sciences, 19*(21), 4095–4100.
  • Usul Afsar, C., Sahin, B., Gunaldi, M., Kılıc Bagir, E., Gumurdulu, D., Burgut, R., Erkisi, M., Kara, I. O., Paydas, S., Karaca, F., & Ercolak, V. (2015). Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in squamous cell carcinoma of the lung. *International Journal of Clinical and Experimental Pathology, 8*(9), 9760–9771.
  • Gunaldi, M., Okuturlar, Y., Gedikbasi, A., Akarsu, C., Karabulut, M., & Kural, A. (2015). Diagnostic importance of S100A9 and S100A12 in breast cancer. *Biomedicine & Pharmacotherapy, 76*, 52–56. https://doi.org/10.1016/j.biopha.2015.10.029
  • Karabulut, M., Alis, H., Bas, K., Karabulut, S., Afsar, C. U., Oguz, H., Gunaldi, M., Akarsu, C., Kones, O., & Aykan, N. F. (2015). Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer. *Molecular and Clinical Oncology, 3*(6), 1255–1267.
  • Gunaldi, M., Kocoglu, H., Okuturlar, Y., Gedikbasi, A., Karabulut, M., & Hursitoglu, M. (2015). Heat shock protein 70 is a useful marker for predicting colorectal cancer. *Journal of BUON, 20*(6), 1464–1470.
  • Afsar, C. U., Gunaldı, M., Okuturlar, Y., Gedikbası, A., Tiken, E. E., Kahraman, S., Karaca, F., Ercolak, V., & Karabulut, M. (2015). Paraoxonase-1 and arylesterase activities in patients with colorectal cancer. *International Journal of Clinical and Experimental Medicine, 8*(11), 21599–21604.
  • Ekmen, N., Helvaci, A., Gunaldi, M., Sasani, H., & Yildirmak, S. T. (2016). Leptin as an important link between obesity and cardiovascular risk factors in men with acute myocardial infarction. *Indian Heart Journal, 68*(2), 132–137. https://doi.org/10.1016/j.ihj.2015.07.032
  • Kocoglu, H., Dogan, H., Oguz, B., Ocak Serin, S., Okuturlar, Y., Gunaldi, M., Erismis, B., Ozdemir, B., Tural, D., Hursitoglu, M., Harmankaya, O., & Kumbasar, A. (2016). Comparison of survival rates, tumor stages, and localization in obese and nonobese patients with gastric cancer. *Gastroenterology Research and Practice, 2016,* 9382750. https://doi.org/10.1155/2016/9382750
  • Gündüz, U. R., Gunaldi, M., Isiksacan, N., Gündüz, S., Okuturlar, Y., & Kocoglu, H. (2016). A new marker for breast cancer diagnosis, human epididymis protein 4: A preliminary study. *Molecular and Clinical Oncology, 5*(2), 355–360.
  • Tanriverdi, O., Menekse, S., Teker, F., Oktay, E., Nur Pilanc, K., Gunaldi, M., Kocar, M., Kacan, T., Bahceci, A., Avci, N., Akman, T., Cokmert, S., Yesil-Cinkir, H., & Teoman Yanmaz, M. (2016). The mean platelet volume may predict the development of isolated bone metastases in patients with breast cancer: A retrospective study of the Young Researchers Committee of the Turkish Oncology Group (TOG). *Journal of BUON, 21*(4), 840–850.
  • Gunaldi, M., Kose, F., Demirci, N. S., Gunduz, S., Ozdemir, N., Kocoglu, H., Okuturlar, Y., Sedef, A. M., Erdem, D., Goksu, S. S., Erdem, G. U., & Yildirim, M. (2018). Adding taxane to platin-5-fluorouracil combination does not improve survival rate in patients ≥ 65 years of age with advanced gastric cancer: A retrospective multicenter study. *Journal of BUON, 23*(2), 416–421.
  • Gunaldi, M., Isiksacan, N., Kocoglu, H., Okuturlar, Y., Gunaldi, O., Topcu, T. O., & Karabulut, M. (2018). The value of serum survivin level in early diagnosis of cancer. *Journal of Cancer Research and Therapeutics, 14*(3), 570–573.
  • Topcu, T. O., Ozdemir, F., Kavgaci, H., Gunaldi, M., Kocoglu, H., Imamoglu, G. I., Mentese, A., Yaman, S. O., Orem, A., & Aydin, F. (2018). The clinical importance of serum urokinase plasminogen activator receptor and carbonic anhydrase IX levels and the effect of anthracycline-based adjuvant chemotherapy on these biomarkers in breast cancer. *Journal of Cancer Research and Therapeutics, 14*(3), 608–613.
  • Okuturlar, Y., Gunaldi, M., Kocoglu, H., Hursitoglu, M., Gedikbasi, A., Acarer, D., Harmankaya, O., & Kumbasar, A. (2018). Serum paraoxonase and arylesterase can be useful markers to predict neoadjuvant chemotherapy requirement in patients with breast cancer. *Journal of Cancer Research and Therapeutics, 14*(Suppl), S362–S367.
  • Şişman, H., Özgen, R., Baysal, D., Sarıakçalı, N., Öztürk, S., Kum, P., Gürel, D., Kanarığ, D., Aslaner, E., Akıl, Y., & Günaldı, M. (2014). Measurement of the knowledge level about breast self-exam among the female employees of a university hospital, Turkey. *Asia-Pacific Journal of Oncology Nursing, 1*(1), 40–45.
  • Deger, C., Telli, F., Gunaldi, M., Keskin, S., Saglam, S., Ozdemir, O., Sar, C., Parali, E., Erdal, E., Sumer, F., Ozel, O., & Asan, S. (2015). The lifetime cost-of-disease (CoD) of metastatic colorectal cancer (mCRC) in Turkey: An expert panel approach for estimation of costs. *Value in Health, 18*(7), A448.
  • Deger, C., Telli, F., Gunaldi, M., Keskin, S., Saglam, S., Ozdemir, O., Sar, C., Parali, E., Erdal, E., Sumer, F., Ozel, O., & Asan, S. (2015). The cost-of-disease of metastatic/inoperable gastrointestinal stromal tumors in Turkey: An expert panel approach for estimation of costs. *Value in Health, 18*(7), A449.
  • Deger, C., Telli, F., Gunaldi, M., Keskin, S., Saglam, S., Ozdemir, O., Sar, C., Parali, E., Erdal, E., Sumer, F., Ozel, O., & Asan, S. (2015). The cost-effectiveness of regorafenib in the treatment of metastatic/inoperable gastrointestinal stromal tumors in Turkey. *Value in Health, 18*(7), A455.
  • Deger, C., Telli, F., Gunaldi, M., Keskin, S., Saglam, S., Ozdemir, O., Sar, C., Parali, E., Erdal, E., Sumer, F., Ozel, O., & Asan, S. (2015). The cost-effectiveness of regorafenib in the treatment of patients with metastatic colorectal cancer (mCRC) who have progressed after standard therapies in Turkey. *Value in Health, 18*(7), A458.
  • Gunaldi, M., Erdem, D., Goksu, S., Gunduz, S., Okuturlar, Y., Tiken, E., Aksoy, H., & Yildirim, M. (2016). Platelet distribution width as a predictor of metastasis in gastric cancer patients. *Journal of Gastrointestinal Cancer.* Advance online publication. https://doi.org/10.1007/s12029-016-9886-5
  • Demir, A., Molinas Mandel, N., Paydas, S., Demir, G., Er, O., Turhal, N. S., Bavbek, S., Eralp, Y., Saip, P. M., Güler, E. N., Aydıner, A., Uluç, B. O., Kılıçkap, S., Üskent, N., Karadurmuş, N., Kaplan, M. A., Yanmaz, M. T., Demir, H., Alan, O., Korkmaz, T., Olgun, P., Uysal, Ö. S., Altundağ, K., Gündüz, Ş., Günaldı, M., Sarı, M., Beypınar, İ., & Başaran, G. (2020). [Article title unavailable]. *Balkan Medical Journal, 37*(2), 104–107. https://doi.org/10.4274/balkanmedj.galenos.2020.2020.2.3
Uluslararası Bilimsel Toplantılarda Sunulan ve Bildiri Kitaplarında (Proceedings) Basılan Bildiriler:
  • Gunaldi, M., Kara, I. O., Afsar, C. U., & Duman, B. B. (2012, June 1–5). Sorafenib in the treatment of metastatic paraganglioma: A case report [Poster presentation]. 2012 ASCO Annual Meeting, Chicago, IL, United States.
  • Duman, B. B., Gunaldi, M., Tasdogan, B. E., Afsar, C. U., Paydas, S., & Gumurdulu, Y. (2012, May–June). Nonalcoholic fatty liver disease after adjuvant therapy in nonmetastatic breast cancer [Poster presentation]. ASCO Annual Meeting, Chicago, IL, United States.
  • Gunaldi, M., Sahin, B., & Tatlı, U. (2011). Osteonecrosis of the jaw in cancer patients treated with bisphosphonates [Poster presentation]. Mediterranean Multidisciplinary Oncology Forum Congress.
  • Tiken, E. E., Günaldı, M., Okuturlar, Y., & Tuna, S. (2014, September 30–October 2). The evaluation of synchronous bilateral breast cancer patients [Poster presentation]. International Breast Cancer Conference, Istanbul, Turkey.
  • Okuturlar, Y., Günaldı, M., Tiken, E. E., Tuna, S., Oztosun, B., Inan, Y., Ercan, T., Harmankaya, O., & Kumbasar, B. (2014, September 30–October 2). Evaluation of body mass index in breast cancer patients [Poster presentation]. International Breast Cancer Conference, Istanbul, Turkey.
  • Günaldı, M., Tiken, E. E., Okuturlar, Y., Tuna, S., & Kapan, S. (2014, September 30–October 2). Neoadjuvant chemotherapy in breast cancer patients: Single centre experience [Poster presentation]. International Breast Cancer Conference, Istanbul, Turkey.
  • Gunaldi, M., Erkisi, M., Afsar, C. U., Ercolak, V., Paydas, S., Kara, I. O., Sahin, B., Gulec, U., & Secilmis, A. (2014). The evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisms in Turkish breast cancer patients receiving tamoxifen treatment [Poster presentation]. ASCO Annual Meeting, Chicago, IL, United States.
  • Afsar, C. U., Sahin, B., Gumurdulu, D., Kılıc Bagir, E., Burgut, R., Erkisi, M., Kara, I. O., Gunaldi, M., & Ercolak, V. (2014, September 26–30). The evaluation of fibroblast growth factor receptor 1 (FGFR1), fibroblast growth factor 2 (FGF2), phosphatidylinositol 3 phosphate kinase (IP3K) expression and their clinical, prognostic significance in early and advanced stage of squamous cell carcinoma of the lung [Poster presentation]. 39th ESMO Congress, Madrid, Spain.
  • Helvaci, A., Çorbacıoğlu, E., & Günaldı, M. (2010, April 15–18). Acute coronary syndrome and its relation with diabetes mellitus and antidiabetic drug [Poster presentation]. 59th ESCVS International Congress in conjunction with the 6th Congress of Update in Cardiology and Cardiovascular Surgery, Cesme, Izmir, Turkey.
  • Okuturlar, Y., Gedikbasi, A., Akalin, N., Gunaldi, M., Yilmaz, D., Karakaya, P., Mert, M., & Harmankaya, O. (2014, June 22–26). Effects of iron therapy on paraoxonase and arylesterase activities in patients with iron deficiency anemia [Poster presentation]. IFCC WorldLab Istanbul 2014, 22nd International Congress of Clinical Chemistry and Laboratory Medicine, Istanbul, Turkey.
  • Afsar, C. U., Gunaldi, M., Okuturlar, Y., Gedikbaşı, A., & Kural, A. (2014). Paraoxonase and arylesterase activities in patients with colorectal cancer [Poster presentation]. Advances in Predictive & Personalized Medicine.
  • Gunaldi, M., Afsar, C. U., Okuturlar, Y., Gedikbaşı, A., Kural, A., & Tiken, E. E. (2014). Can heat shock protein 70 be a target therapy in breast cancer? [Poster presentation]. Advances in Predictive & Personalized Medicine.
  • Okuturlar, Y., Gunaldi, M., Gedikbaşı, A., Kural, A., & Acarer, D. (2014). Breast cancer and paraoxonase activity [Poster presentation]. Advances in Predictive & Personalized Medicine.
  • Isıksacan, N., Koşer, M., Gunaldi, M., & Ördekçi, S. (2014). C-reactive protein (CRP) measurement using point of care (POC) devices [Poster presentation]. Advances in Predictive & Personalized Medicine.
  • Oztosun, B., Okuturlar, Y., Gunaldi, M., Soyluk, S., Biricik, Ö., Mert, M., Sayilan, S., Orman, M., & Kaptanoğulları, Ö. (2014). An aggressive malignant insulinoma: A case report [Poster presentation]. European Congress of Endocrinology.
  • Abbasoğlu, D., Gunaldi, M., Sivas, H., Yakıcıer, M. C., & Hızel, H. C. (2014). The factors affecting UGT1A1 enzyme activity of irinotecan drug response in Turkish population [Poster presentation]. 7th Santorini Conference on Systems Personalized Health and Therapy.
  • Gunaldi, M., & Helvaci, A. (2010, April 15–18). Alteration in serum levels of selenium and glutathione peroxidase in acute myocardial infarction [Poster presentation]. 59th ESCVS International Congress in conjunction with the 6th Congress of Update in Cardiology and Cardiovascular Surgery, Cesme, Izmir, Turkey.
  • Günaldı, M., Tiken, E. E., Okuturlar, Y., Tuna, S., & Kapan, S. (2014). Neoadjuvant chemotherapy in breast cancer patients: Single centre experience [Poster presentation]. International Breast Cancer Conference, Istanbul, Turkey.
  • Okuturlar, Y., Tiken, E. E., Tuna, S., Oztosun, B., Inan, Y., Ercan, T., Harmankaya, O., & Kumbasar, B. (2014). Evaluation of body mass index in breast cancer patients [Poster presentation]. International Breast Cancer Conference, Istanbul, Turkey.
  • Günaldı, M., Gürgenyataği, D., Göksu, S., Gülenay, Ş., Yildirim, M., Tiken, E., Okuturlar, Y., & Kahraman, S. (2014). A factor that predicts occurrence of metastasis on stomach cancer patients: PDW [Poster presentation]. 4th International Gastrointestinal Cancer Conference.
  • Okuturlar, Y., Günaldı, M., Gedikbaşı, A., Kural, A., & Acarer, D. (2015). Breast cancer and paraoxonase activity [Poster presentation]. Cancer International Symposium on Advances in Predictive & Personalized Medicine.
  • Gunaldi, M., Goksu, S., Gunduz, S., Okuturlar, Y., Tiken, E., Kahraman, S., & Isıksacan, N. (2015, September 6–9). Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: A multicenter study [Poster presentation]. 4th European Congress of Immunology, Vienna, Austria.
  • Gunaldi, M., Okuturlar, Y., Kural, A., Akarsu, C., Karabulut, M., & Gedikbasi, A. (2015, September 6–9). Clinical importance of S100A9 and S100A12 in breast cancer [Poster presentation]. 4th European Congress of Immunology, Vienna, Austria.
  • Gunaldi, M., Isıksacan, N., Okuturlar, Y., Kocoglu, H., & Gunaldi, O. (2015, September 6–9). Clinical significance of serum survivin in cancer patients [Poster presentation]. 4th European Congress of Immunology, Vienna, Austria.
Yazılan Ulusal/Uluslararası Kitaplar veya Kitaplardaki Böümler
  • Yıldırım, Y., Günaldı, M., & Karaarslan, S. (2013). Kemoterapötik ve moleküler hedefe yönelik tedavide sınıflama, kullanım ve toksisite. In H. Onat (Ed.), Kanser kemoterapi el kitabı. Çukurova Nobel Kitabevi.
  • Günaldı, Ö., & Günaldı, M. (2014). Ommaya rezervuarı. In Nöroşirurjide şant cerrahisi. Selen Yayıncılık.
Yazılan Ulusal/Uluslararası Kitaplar
  • Günaldı, M. (2022, Şubat). Gastrointestinal sistem kanserlerinde güncel yaklaşımlar – Metastatik iyi farklılaşmış gastrointestinal ve pankreas nöroendokrin tümörlerde tedavi.
  • Günaldı, Ö., & Günaldı, M. (2014). Ommaya rezervuarı. In Nöroşirurjide şant cerrahisi. Selen Yayıncılık.
  • Yıldırım, Y., Günaldı, M., & Karaarslan, S. (2013). Kemoterapötik ve moleküler hedefe yönelik tedavide sınıflama, kullanım ve toksisite. In H. Onat (Ed.), Kanser kemoterapi el kitabı. Çukurova Nobel Kitabevi.
Ulusal Hakemli Dergilerde Yayımlanan Makaleler:
  • Günaldi, M., Duman, B. B., Erçolak, V., Afşar, Ç. U., Kara, İ. O., & Şahin, B. (2012). Sorafenib ilişkili üç farklı deri toksisitesi: Olgu sunumu. Turkish Journal of Dermatology.
  • Yılmaz, G., Adaş, M., Helvacı, A., Altıntaş, N., & Günaldi, M. (2013). Evaluation of respiratory functions in subclinical and clinical hypothyroidism. Journal of Turgut Ozal Medical Center.
  • Tiken, E. E., Günaldi, M., Okuturlar, Y., & Sever, N. (2014). İnvaziv lobuler meme kanserinin mideye metastazı: Olgu sunumu. Türk Onkoloji Dergisi, 29(4), 157–161. https://doi.org/10.5505/tjoncol.2014.1178
  • Günaldi, M., Duman, B. B., Afşar, Ç. U., Günaldı, Ö., & Şahin, B. (2014). Temporal kemik yerleşimli langerhans hücreli histiositozis: Bir olgu sunumu. Göztepe Tıp Dergisi.
  • Karaca, F., Erçolak, V., Afşar, Ç. U., & Günaldi, M. (2015). Memenin diffüz büyük B hücreli lenfoması. Çukurova Medical Journal.
  • Günaldi, M., & Köksal Erkiş, M. (2014). Glioblastome multiformede kemoterapi. Klinik Tıp Bilimleri.
  • Gözkaman, A., Okuturlar, Y., Kanat, Ö., Günaldi, M., Serin, S. O., Saydaroğlu, Ö., Kumbasar, A., & Evrensel, T. (2015). Küçük hücreli akciğer kanserli hastalarda C-Kit (CD117) ekspresyonu. Haseki Tıp Bülteni, 53, 67–71. https://doi.org/10.4274/haseki.2078
  • Okuturlar, Y., Günaldi, M., Tiken, E. E., Tuna, S., Öztosun, B., Özdeminan, Y., Ercan, T., Harmankaya, Ö., & Kumbasar, A. (2015). Fazla kilo ve obezitenin meme kanseri alt tipleri üzerine etkisi. Journal of Clinical and Analytical Medicine.
  • Tiken, E. E., Günaldi, M., Okuturlar, Y., & Tuna, S. (2015). Senkron bilateral meme kanserli hastaların değerlendirilmesi. Istanbul Medical Journal. Advance online publication.
  • Okuturlar, Y., Mert, M., Soyluk, Ö., Enki, S., Sayilan, S., Gönenç, M., Günaldi, M., Kumbasar, A., Aliş, H., & Harmankaya, Ö. (2015). İleri yaşta görülen nadir bir hipoglisemi nedeni: İnsülinoma. Bakırköy Tıp Dergisi.
  • Günaldi, M., Duman, B. B., Erçolak, V., Afşar, Ç. U., Paydaş, S., Köksal Erkiş, M., Kara, İ. O., Şahin, B., & Gönlüsen, G. (2014). Osteosarkomların retrospektif değerlendirmesi. Journal of Clinical and Analytical Medicine.
  • Günaldi, M. (2014). Meme kanseri risk faktörleri. Klinik Tıp Aile Hekimliği Dergisi.
  • Özkara, İ. Ö., & Günaldi, M. (2014). Mide kanseri: Önleme, risk faktörleri ve prognoz. Klinik Tıp Aile Hekimliği Dergisi.
Bilimsel Toplantılarda Sunulan ve Bildiri Kitaplarında Basılan Bildiriler:
  • Günaldı, M., Duman, B. B., Erçolak, V., Afşar, Ç. U., Paydaş, S., Kara, İ. O., Erkişi, M., & Şahin, B. (2012, March 21–25). Trastuzumab ilişkili kardiyotoksisiteye epirubisin ve doksorubisinin katkısının araştırılması [Poster presentation]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
  • Günaldı, M., Paydaş, S., Afşar, Ç. U., Erçolak, V., Duman, B. B., & Doran, F. (2012, March 21–25). Tuberoskleroz ve malign melanom birlikteliği [Poster presentation]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
  • Günaldı, M. (2012, March 21–25). Bilateral over metastazı ile tanı konan primer appendiks adenokarsinomu [Poster presentation]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
  • Günaldı, M., Erkişi, M., Afşar, Ç. U., Duman, B. B., & Erçolak, V. (2012, March 21–25). Richter sendromu [Poster presentation]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
  • Duman, B. B., Afşar, Ç. U., Günaldı, M., Erkişi, M., Kara, İ. O., Şahin, B., & Kum, P. (2013, April 19–23). Meme kanserli hastalarda adjuvan/neoadjuvan kemoterapi deneyimimiz [Poster presentation]. 20. Ulusal Kanser Kongresi, Antalya, Turkey.
  • Günaldı, M., Kara, İ. O., Afşar, Ç. U., Erçolak, V., & Duman, B. B. (2012, March 21–25). Akromegaliye eşlik eden malign mezankimal tümör [Poster presentation]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
  • Erçolak, V., Paydaş, S., Şeydaoğlu, G., Günaldı, M., Afşar, Ç. U., & Duman, B. B. (2013). Hodgkin lenfoma olgularında retrospektif değerlendirme [Poster presentation]. 5. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
  • Gunaldi, M., Okuturlar, Y., & Tiken, E. E. (2014, September). Geriatrik meme kanseri hastalarında moleküler alt grup değerlendirmesi [Poster presentation]. 1. Geriatri Onkoloji Kongresi, Antalya, Turkey.
  • Günaldı, M., Erkişi, M., Afşar, Ç. U., Duman, B. B., & Erçolak, V. (2012, March 21–25). Akciğer adenokarsinomlu hastada alfa-2 globulin piki [Poster presentation]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
  • Duman, B. B., Şahin, B., Erkişi, M., Paydaş, S., Kara, İ. O., Afşar, Ç. U., Günaldı, M., Erçolak, V., & Kum, P. (2012, March 21–25). Metastatik renal hücreli karsinomda sitoredüktif nefrektominin sağkalım üzerine etkisi [Poster presentation]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
  • Günaldı, M., Şahin, B., Duman, B. B., Erçolak, V., & Afşar, Ç. U. (2012, March 21–25). Bevacizumab çene osteonekrozu için bir risk faktörü müdür? [Poster presentation]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
  • Türk Tıbbi Onkoloji Derneği (TTOD) – Yönetim Kurulu (2020–2022)
  • Interdisipliner Onkoloji Derneği (IDOD)
  • Türk Nöroonkoloji Derneği
  • European Society of Medical Oncology (ESMO)
  • Doç. Dr. Metin Karan Makale Ödülü (2013)
  • Tıbbi Onkoloji Derneği Bildiri Ödülü (2012)
  • Poster Bildiri Üçüncülük Ödülü
  • A’dan Z’ye Biyolojik Tedaviler Kursu (2023)
  • Türk Tıbbi Onkoloji Derneği Kursları (2020–2022)
  • Palyatif Bakım Kongresi (2018)
  • Uludağ Tıbbi Onkoloji Sempozyumu (2018)
Hekime Sor
Formu Eksiksiz Doldurunuz.